Heart Failure POC & LOC Devices Market Size, Share, and Analysis, By Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Technology (Microfluidics, Array-Based Systems, Others), By End User (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory) and Regional Forecasts, 2022-2032
Heart Failure POC & LOC Devices Market Size, Share, and Analysis, By Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Technology (Microfluidics, Array-Based Systems, Others), By End User (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW
Heart Failure POC & LOC Devices Market size was USD 66.11 million in 2021 and projected t%li%grow from USD 89.6 million in 2023 t%li%USD 360.1 million by 2032, exhibiting a CAGR of 16.7% during the forecast period.
Heart failure is lifetime disorder wherein the heart muscle is unable t%li%pump sufficient blood t%li%satisfy the body's demands for oxygen and blood. The LOC technology has the potential t%li%improve disease detection, whilst the POC devices assist in evaluating specific cardiac signs like troponin. POC testing enables treatment decisions much faster. The devices are either currently under development as prototypes or are already accessible commercially.
MARKET HIGHLIGHTS
Heart Failure POC & LOC Devices Market is expected t%li%reach USD 360.1 million, growing at a CAGR of 16.7% during the forecast period owing t%li%the miniaturization of devices, the LOC (lab-on-chip) technology presenting great potential t%li%enhance diagnosis of disease in terms of throughput, cost-effectiveness, analysis, and ease-of-operation. R&D is anticipated t%li%accelerate the growth of the Heart Failure POC & LOC Devices Market in future besides working toward the creation of novel LOC-based assays for the diagnosis of cardiovascular disease (CVD).
Heart Failure POC and LOC Devices Market Segments:
Growth Drivers
Growing Number of POC Tests and Rising Awareness for their Effectiveness is Expected t%li%Boost the Market Growth
Rising Cases of CVDs and Growing Patient Population are Expected t%li%Boost the Market Growth
Restraint
Absence of Clear-cut Reimbursement for POC Devices t%li%Restrain the Market Growth
Key Players
PRODUCT OVERVIEW
Heart Failure POC & LOC Devices Market size was USD 66.11 million in 2021 and projected t%li%grow from USD 89.6 million in 2023 t%li%USD 360.1 million by 2032, exhibiting a CAGR of 16.7% during the forecast period.
Heart failure is lifetime disorder wherein the heart muscle is unable t%li%pump sufficient blood t%li%satisfy the body's demands for oxygen and blood. The LOC technology has the potential t%li%improve disease detection, whilst the POC devices assist in evaluating specific cardiac signs like troponin. POC testing enables treatment decisions much faster. The devices are either currently under development as prototypes or are already accessible commercially.
MARKET HIGHLIGHTS
Heart Failure POC & LOC Devices Market is expected t%li%reach USD 360.1 million, growing at a CAGR of 16.7% during the forecast period owing t%li%the miniaturization of devices, the LOC (lab-on-chip) technology presenting great potential t%li%enhance diagnosis of disease in terms of throughput, cost-effectiveness, analysis, and ease-of-operation. R&D is anticipated t%li%accelerate the growth of the Heart Failure POC & LOC Devices Market in future besides working toward the creation of novel LOC-based assays for the diagnosis of cardiovascular disease (CVD).
Heart Failure POC and LOC Devices Market Segments:
- Test Type
- Proteomic Testing
- Metabolomic Testing
- Genomic Testing
- Technology
- Microfluidics
- Array-Based Systems
- Others
- End User
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
Growth Drivers
Growing Number of POC Tests and Rising Awareness for their Effectiveness is Expected t%li%Boost the Market Growth
Rising Cases of CVDs and Growing Patient Population are Expected t%li%Boost the Market Growth
Restraint
Absence of Clear-cut Reimbursement for POC Devices t%li%Restrain the Market Growth
Key Players
- Abbott
- Siemens Healthineers
- Roche Diagnostics USA
- bioMйrieux S.A
- Quidel Corporation
- Trinity BiotechInstrumentation Laboratory
- Butterfly Network
- Jant Pharmacal Corporation
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3. Heart Failure POC & LOC Devices Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Heart Failure POC & LOC Devices Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. HEART FAILURE POC & LOC DEVICES MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. MARKET ANALYSIS
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2.Economic
8.2.3.Social
8.2.4.Technological
9. HEART FAILURE POC & LOC DEVICES MARKET
9.1. Overview
9.2.Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Test Type
10.3.1.1.Proteomic Testing
10.3.1.1.1.By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Metabolomic Testing
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2.Market Share (%) 2022-2032F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.1.3. Genomic Testing
10.3.1.3.1. By Value (USD Million) 2022-2032F
10.3.1.3.2.Market Share (%) 2022-2032F
10.3.1.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.By Technology
10.3.2.1. Microfluidics
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2.Market Share (%) 2022-2032F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.2.Array-Based Systems
10.3.2.2.1.By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3.Others
10.3.2.3.1.By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.By End User
10.3.3.1. Clinics
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2.Market Share (%) 2022-2032F
10.3.3.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.2.Hospitals
10.3.3.2.1.By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.3.Home
10.3.3.3.1.By Value (USD Million) 2022-2032F
10.3.3.3.2.Market Share (%) 2022-2032F
10.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.4.Assisted Living Healthcare Facilities
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2.Market Share (%) 2022-2032F
10.3.3.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.5.Laboratory
10.3.3.5.1. By Value (USD Million) 2022-2032F
10.3.3.5.2.Market Share (%) 2022-2032F
10.3.3.5.3.Y-o-Y Growth (%) 2022-2032F
11.NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test Type
11.3.2. By Technology
11.3.3. By End User
11.4.Country
11.4.1. United States
11.4.2.Canada
12. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test Type
12.3.2.By Technology
12.3.3.By End User
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. ASIA HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test Type
13.3.2.By Technology
13.3.3.By End User
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. MIDDLE EAST AND AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test Type
14.3.2.By Technology
14.3.3.By End User
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test Type
15.3.2.By Technology
15.3.3.By End User
15.4. Country
15.4.1.Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. COMPETITIVE LANDSCAPE
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. COMPANY PROFILES
17.1.Abbott
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4.Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Siemens Healthineers
17.3. Roche Diagnostics USA
17.4. bioMйrieux S.A
17.5. Quidel Corporation
17.6. Trinity BiotechInstrumentation Laboratory
17.7. Butterfly Network
17.8. Jant Pharmacal Corporation
17.9. Other Prominent Players
18. APPENDIX
19. CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3. Heart Failure POC & LOC Devices Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Heart Failure POC & LOC Devices Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. HEART FAILURE POC & LOC DEVICES MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. MARKET ANALYSIS
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2.Economic
8.2.3.Social
8.2.4.Technological
9. HEART FAILURE POC & LOC DEVICES MARKET
9.1. Overview
9.2.Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Test Type
10.3.1.1.Proteomic Testing
10.3.1.1.1.By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Metabolomic Testing
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2.Market Share (%) 2022-2032F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.1.3. Genomic Testing
10.3.1.3.1. By Value (USD Million) 2022-2032F
10.3.1.3.2.Market Share (%) 2022-2032F
10.3.1.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.By Technology
10.3.2.1. Microfluidics
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2.Market Share (%) 2022-2032F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.2.Array-Based Systems
10.3.2.2.1.By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3.Others
10.3.2.3.1.By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.By End User
10.3.3.1. Clinics
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2.Market Share (%) 2022-2032F
10.3.3.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.2.Hospitals
10.3.3.2.1.By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.3.Home
10.3.3.3.1.By Value (USD Million) 2022-2032F
10.3.3.3.2.Market Share (%) 2022-2032F
10.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.4.Assisted Living Healthcare Facilities
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2.Market Share (%) 2022-2032F
10.3.3.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.5.Laboratory
10.3.3.5.1. By Value (USD Million) 2022-2032F
10.3.3.5.2.Market Share (%) 2022-2032F
10.3.3.5.3.Y-o-Y Growth (%) 2022-2032F
11.NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test Type
11.3.2. By Technology
11.3.3. By End User
11.4.Country
11.4.1. United States
11.4.2.Canada
12. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test Type
12.3.2.By Technology
12.3.3.By End User
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. ASIA HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test Type
13.3.2.By Technology
13.3.3.By End User
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. MIDDLE EAST AND AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test Type
14.3.2.By Technology
14.3.3.By End User
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test Type
15.3.2.By Technology
15.3.3.By End User
15.4. Country
15.4.1.Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. COMPETITIVE LANDSCAPE
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. COMPANY PROFILES
17.1.Abbott
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4.Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Siemens Healthineers
17.3. Roche Diagnostics USA
17.4. bioMйrieux S.A
17.5. Quidel Corporation
17.6. Trinity BiotechInstrumentation Laboratory
17.7. Butterfly Network
17.8. Jant Pharmacal Corporation
17.9. Other Prominent Players
18. APPENDIX
19. CONSULTANT RECOMMENDATION
